Clinical trial
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and…
NCT00318513 · Premiere Oncology of Arizona, Other · Unknown status
Key facts
| NCT number | NCT00318513 |
|---|---|
| Title | Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema |
| Official title | Phase I Study Evaluating the Safety of Bevacizumab in Women With a History of Breast Cancer Suffering From Moderate to Severe Upper Extremity Lymphedema |
| Lead sponsor | Premiere Oncology of Arizona, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphedema |
| Intervention type | Drug |
| Interventions | Bevacizumab |
| Enrollment | 35 |
| First posted | Apr 26, 2006 |
| Last update posted | May 10, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: